★
HIMS
Hims & Hers Health Inc · Health Care
FCF$280mC
Rev+32.8%A
D/E0.27A-
P/S2.3xA-
PEG——
77Score
$23.851Y Target$32.20Near-term target
5Y Target$47.97Compound horizon
10Y Target$124.83Long-dated conviction
FCF$280mTTM · 03/26C
FCF $280m — modest; watch for margin expansion · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+32.8%TTM YoYA
Revenue +32.8% — hypergrowth, top decile · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.27totalA-
D/E 0.27 — conservative leverage, strong balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S2.3xA-
P/S 2.3x — cheap for any tech/growth name
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $5.5b. Down 66% from 52-week high of $70.43 — deep drawdown territory. Revenue growing +33% — in hypergrowth territory.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -0.6%) — path to GAAP profitability is the core thesis risk. Down 66% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Beta 2.43 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return.
Horizon
1-3 yr $32.20 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $47.97 — requires the platform / technology to reach commercial scale. 10 yr $124.83 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · HIMS
Shares to buy
83
Position size
$1,980
4.0% of portfolio
Stop price
$17.89
25% below $23.85
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.